Financhill
Buy
58

CVS Quote, Financials, Valuation and Earnings

Last price:
$55.67
Seasonality move :
6.43%
Day range:
$55.25 - $56.55
52-week range:
$43.56 - $80.75
Dividend yield:
4.72%
P/E ratio:
14.30x
P/S ratio:
0.19x
P/B ratio:
0.95x
Volume:
6.6M
Avg. volume:
13.3M
1-year change:
-22.9%
Market cap:
$70.9B
Revenue:
$357.8B
EPS (TTM):
$3.94

Analysts' Opinion

  • Consensus Rating
    CVS Health has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $65.58, CVS Health has an estimated upside of 16.38% from its current price of $56.35.
  • Price Target Downside
    According to analysts, the lowest downside price target is $48.01 representing 100% downside risk from its current price of $56.35.

Fair Value

  • According to the consensus of 21 analysts, CVS Health has 16.38% upside to fair value with a price target of $65.58 per share.

CVS vs. S&P 500

  • Over the past 5 trading days, CVS Health has underperformed the S&P 500 by -1.17% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • CVS Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • CVS Health has grown year-over-year revenues for 46 quarters straight. In the most recent quarter CVS Health reported revenues of $95.4B.

Earnings Growth

  • CVS Health earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter CVS Health reported earnings per share of $0.07.
Enterprise value:
126.9B
EV / Invested capital:
--
Price / LTM sales:
0.19x
EV / EBIT:
13.20x
EV / Revenue:
0.34x
PEG ratio (5yr expected):
0.07x
EV / Free cash flow:
75.24x
Price / Operating cash flow:
42.40x
Enterprise value / EBITDA:
8.94x
Gross Profit (TTM):
$52.4B
Return On Assets:
2%
Net Income Margin (TTM):
1.36%
Return On Equity:
6.68%
Return On Invested Capital:
3.61%
Operating Margin:
2.1%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $315.2B $347.8B $368.9B $89.8B $95.4B
Gross Profit $54.4B $54.4B $52.4B $13.6B $12.6B
Operating Income $16.2B $15B $10.7B $3.7B $2B
EBITDA $11B $18.4B $14.2B $4.8B $2B
Diluted EPS $2.45 $6.63 $3.94 $1.75 $0.07
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $59.2B $60.8B $68.3B $70.1B $67.3B
Total Assets $232.9B $234.9B $231.2B $251.3B $252.4B
Current Liabilities $62B $64.7B $72.4B $81.6B $84.6B
Total Liabilities $163.8B $160.3B $160.2B $176.8B $177.3B
Total Equity $69.1B $74.6B $71B $74.5B $75.1B
Total Debt $67B $58.4B $52.2B $61.9B $65.5B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $22.1B $14.1B $4.6B $2.7B -$745M
Cash From Investing -$6.4B -$19.8B -$8.3B -$771M -$3.3B
Cash From Financing -$11.2B $1.5B -$2.5B -$2.7B -$1.6B
Free Cash Flow $19.5B $11.3B $1.7B $2.2B -$1.4B
CVS
Sector
Market Cap
$70.9B
$43.1M
Price % of 52-Week High
69.78%
47.72%
Dividend Yield
4.72%
0%
Shareholder Yield
7.52%
-0.75%
1-Year Price Total Return
-22.9%
-33.05%
Beta (5-Year)
0.613
0.754
Dividend yield:
4.72%
Annualized payout:
$2.42
Payout ratio:
66.07%
Growth streak:
2 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $56.32
200-day SMA
Sell
Level $57.38
Bollinger Bands (100)
Buy
Level 49.55 - 61.43
Chaikin Money Flow
Buy
Level 710.4M
20-day SMA
Buy
Level $52.80
Relative Strength Index (RSI14)
Buy
Level 67.31
ADX Line
Buy
Level 53.03
Williams %R
Neutral
Level -26.9476
50-day SMA
Buy
Level $51.96
MACD (12, 26)
Buy
Level 1.93
25-day Aroon Oscillator
Buy
Level 76
On Balance Volume
Sell
Level -107.4M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.2589)
Sell
CA Score (Annual)
Level (-0.4906)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.7548)
Buy
Piotroski F Score (Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.

Stock Forecast FAQ

In the current month, CVS has received 11 Buy ratings 10 Hold ratings, and 0 Sell ratings. The CVS average analyst price target in the past 3 months is $65.58.

  • Where Will CVS Health Stock Be In 1 Year?

    According to analysts, the consensus estimate is that CVS Health share price will rise to $65.58 per share over the next 12 months.

  • What Do Analysts Say About CVS Health?

    Analysts are divided on their view about CVS Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CVS Health is a Sell and believe this share price will drop from its current level to $48.01.

  • What Is CVS Health's Price Target?

    The price target for CVS Health over the next 1-year time period is forecast to be $65.58 according to 21 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.

  • Is CVS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for CVS Health is a Buy. 11 of 21 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of CVS?

    You can purchase shares of CVS Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CVS Health shares.

  • What Is The CVS Health Share Price Today?

    CVS Health was last trading at $55.67 per share. This represents the most recent stock quote for CVS Health. Yesterday, CVS Health closed at $56.35 per share.

  • How To Buy CVS Health Stock Online?

    In order to purchase CVS Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

AT&T vs Target Stock: Which Is Best?
AT&T vs Target Stock: Which Is Best?

One a telecom, another a retailer. Both are expected to…

Duquesne Family Office Portfolio Overview
Duquesne Family Office Portfolio Overview

Stanley Druckenmiller has an exemplary history and track record trading…

Why Is Qualcomm Stock Going Up?
Why Is Qualcomm Stock Going Up?

Why Is Qualcomm Stock Going Up? QUALCOMM (NASDAQ:QCOM) share price…

Stock Ideas

Buy
58
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Sell
40
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 99x

Alerts

Buy
78
FLXS alert for Feb 5

Flexsteel Industries [FLXS] is down 5.98% over the past day.

Buy
92
PLTR alert for Feb 5

Palantir Technologies [PLTR] is down 2.41% over the past day.

Sell
1
ATKR alert for Feb 5

Atkore [ATKR] is up 2.46% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock